Immunogenicity, Impact on Carriage and Reactogenicity of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine in Kenyan Children Aged 1–4 Years: A Randomized Controlled Trial

• Laura L. Hammitt ,

  * E-mail: lhammitt@jhsph.edu

  Affiliations KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• John Ojal,

  Affiliation KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya

  ⨯
• Mahfudh Bashraheil,

  Affiliation KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya

  ⨯
• Susan C. Morpeth,

  Affiliations KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Angela Karani,

  Affiliation KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya

  ⨯
• Ahsan Habib,

  Affiliation GlaxoSmithKline Vaccines, Wavre, Belgium

  ⨯
• Dorota Borys,

  Affiliation GlaxoSmithKline Vaccines, Wavre, Belgium

  ⨯
• David Goldblatt,

  Affiliation Institute of Child Health, University College London, London, United Kingdom

  ⨯
• J. Anthony G Scott

  Affiliations KEMRI-Wellcome Trust Research Programme, Centre for Geographic Medicine-Coast, Kilifi, Kenya, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom

  ⨯